Table 3.

Symptom component characteristics (*** = p < 0.001, ** = p < 0.01, * = p < 0.05, . = p <0.1)

	Coefficients:	B	SEM	t value	Pr(>|t|)
Component 1	(Intercept)	0.27	1.23	0.22	0.83
F(7,109) = 0.4887, p = 0.841	Gender	−0.01	0.22	−0.05	0.96
Adj R^2 = 0.031	Site (1=UCSD,2=UCLA)	−0.19	0.20	−0.95	0.35
Negative Valence Appraisal	Age	0.00	0.01	−0.19	0.85
	No Medication	0.14	1.03	0.13	0.90
	Benzodiazepine	−0.07	1.14	−0.06	0.95
	SSRI	0.12	1.07	0.11	0.91
	Other	−0.46	1.09	−0.43	0.67
Component 2	(Intercept)	−0.04	1.18	−0.04	0.97
F(7,109) =1.735, p = 0.1083	Gender	0.02	0.21	0.09	0.93
Adj R^2 = 0.04245	Site (1=UCSD,2=UCLA)	−0.56	0.19	−2.96	0.00
Positive Valence Appraisal	Age	−0.01	0.01	−0.88	0.38
	No Medication	1.13	0.99	1.14	0.26
	Benzodiazepine	0.81	1.09	0.74	0.46
	SSRI	1.12	1.03	1.08	0.28
	Other	0.71	1.04	0.68	0.50
Component 3	(Intercept)	2.76	1.11	2.49	0.01*
F(7,109) = 3.465, p = 0.002176	Gender	−0.70	0.19	−3.58	0.00***
Adj R^2 = 0.1295	Site (1=UCSD,2=UCLA)	−0.36	0.18	−2.01	0.05*
Antagonistic Disinhibition	Age	−0.02	0.01	−3.06	0.00**
	No Medication	−0.26	0.93	−0.28	0.78
	Benzodiazepine	−0.66	1.03	−0.64	0.52
	SSRI	−0.17	0.97	−0.18	0.86
	Other	−0.46	0.98	−0.47	0.64
Component 4	(Intercept)	0.33	1.13	0.29	0.77
F(4,115) = 5.125, p = 0.0007769	Gender	0.35	0.20	1.77	0.08.
Adj R^2 = 0.1218	Site (1=UCSD,2=UCLA)	0.32	0.18	1.76	0.08.
Avoidant Detachment	Age	−0.03	0.01	−3.39	0.00***
	No Medication	−0.63	0.95	−0.66	0.51
	Benzodiazepine	−0.29	1.05	−0.27	0.78
	SSRI	−0.19	0.99	−0.19	0.85
	Other	−0.40	1.00	−0.40	0.69
WHODAS 2.0	(Intercept)	22.68	0.52	43.98	< 2e-16***
F(5,114) = 20.52, p <8.806e-13	Negative Valence Appraisal	2.95	0.52	5.70	0.00***
Adj R^2 =0.3962	Positive Valence Appraisal	−2.74	0.52	−5.29	0.00***
	Antagonistic Disinhibition	1.41	0.52	2.72	0.01**
	Avoidant Detachment	1.95	0.52	3.77	0.00***